July 19, 2019  |  

A benchmark study on error assessment and quality control of CCS reads derived from the PacBio RS.

Authors: Jiao, Xiaoli and Zheng, Xin and Ma, Liang and Kutty, Geetha and Gogineni, Emile and Sun, Qiang and Sherman, Brad T and Hu, Xiaojun and Jones, Kristine and Raley, Castle and Tran, Bao and Munroe, David J and Stephens, Robert and Liang, Dun and Imamichi, Tomozumi and Kovacs, Joseph A and Lempicki, Richard A and Huang, Da Wei

PacBio RS, a newly emerging third-generation DNA sequencing platform, is based on a real-time, single-molecule, nano-nitch sequencing technology that can generate very long reads (up to 20-kb) in contrast to the shorter reads produced by the first and second generation sequencing technologies. As a new platform, it is important to assess the sequencing error rate, as well as the quality control (QC) parameters associated with the PacBio sequence data. In this study, a mixture of 10 prior known, closely related DNA amplicons were sequenced using the PacBio RS sequencing platform. After aligning Circular Consensus Sequence (CCS) reads derived from the above sequencing experiment to the known reference sequences, we found that the median error rate was 2.5% without read QC, and improved to 1.3% with an SVM based multi-parameter QC method. In addition, a De Novo assembly was used as a downstream application to evaluate the effects of different QC approaches. This benchmark study indicates that even though CCS reads are post error-corrected it is still necessary to perform appropriate QC on CCS reads in order to produce successful downstream bioinformatics analytical results.

Journal: Journal of data mning in genomics & proteomics
DOI: 10.4172/2153-0602.1000136
Year: 2013

Read publication

Talk with an expert

If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.